Literature DB >> 26022626

Arresting the colonial destiny of metastatic seeds with DNA aptamers.

Gerolama Condorelli1, Paloma H Giangrande2, Vittorio de Franciscis3.   

Abstract

Mesh：

Year:  2015        PMID： 26022626      PMCID： PMC5189516          DOI： 10.1038/mt.2015.85

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  13 in total

1.  Blocking the adhesion cascade at the premetastatic niche for prevention of breast cancer metastasis.

Authors:  Shin-Ae Kang; Nafis Hasan; Aman P Mann; Wei Zheng; Lichao Zhao; Lynsie Morris; Weizhu Zhu; Yan D Zhao; K Stephen Suh; William C Dooley; David Volk; David G Gorenstein; Massimo Cristofanilli; Hallgeir Rui; Takemi Tanaka
Journal:  Mol Ther       Date:  2015-03-27       Impact factor: 11.454

2.  Targeting the hsp70 gene delays mammary tumor initiation and inhibits tumor cell metastasis.

Authors:  J Gong; D Weng; T Eguchi; A Murshid; M Y Sherman; B Song; S K Calderwood
Journal:  Oncogene       Date:  2015-02-09       Impact factor: 9.867

Review 3.  Targeting cancer cells with nucleic acid aptamers.

Authors:  Laura Cerchia; Vittorio de Franciscis
Journal:  Trends Biotechnol       Date:  2010-08-17       Impact factor: 19.536

4.  Bone marrow endothelium-targeted therapeutics for metastatic breast cancer.

Authors:  Junhua Mai; Yi Huang; Chaofeng Mu; Guodong Zhang; Rong Xu; Xiaojing Guo; Xiaojun Xia; David E Volk; Ganesh L Lokesh; Varatharasa Thiviyanathan; David G Gorenstein; Xuewu Liu; Mauro Ferrari; Haifa Shen
Journal:  J Control Release       Date:  2014-05-10       Impact factor: 9.776

5.  Identification of thioaptamer ligand against E-selectin: potential application for inflamed vasculature targeting.

Authors:  Aman P Mann; Anoma Somasunderam; René Nieves-Alicea; Xin Li; Austin Hu; Anil K Sood; Mauro Ferrari; David G Gorenstein; Takemi Tanaka
Journal:  PLoS One       Date:  2010-09-30       Impact factor: 3.240

Review 6.  Molecular basis of metastasis.

Authors:  Anne C Chiang; Joan Massagué
Journal:  N Engl J Med       Date:  2008-12-25       Impact factor: 91.245

7.  Circulating tumor cells from prostate cancer patients interact with E-selectin under physiologic blood flow.

Authors:  Gunjan Gakhar; Vicente N Navarro; Madelyn Jurish; Guang Yu Lee; Scott T Tagawa; Naveed H Akhtar; Marco Seandel; Yue Geng; He Liu; Neil H Bander; Paraskevi Giannakakou; Paul J Christos; Michael R King; David M Nanus
Journal:  PLoS One       Date:  2013-12-27       Impact factor: 3.240

8.  Tracking the origins and drivers of subclonal metastatic expansion in prostate cancer.

Authors:  Matthew K H Hong; Geoff Macintyre; David C Wedge; Peter Van Loo; Keval Patel; Sebastian Lunke; Ludmil B Alexandrov; Clare Sloggett; Marek Cmero; Francesco Marass; Dana Tsui; Stefano Mangiola; Andrew Lonie; Haroon Naeem; Nikhil Sapre; Pramit M Phal; Natalie Kurganovs; Xiaowen Chin; Michael Kerger; Anne Y Warren; David Neal; Vincent Gnanapragasam; Nitzan Rosenfeld; John S Pedersen; Andrew Ryan; Izhak Haviv; Anthony J Costello; Niall M Corcoran; Christopher M Hovens
Journal:  Nat Commun       Date:  2015-04-01       Impact factor: 14.919

Review 9.  Aptamers as therapeutics.

Authors:  Anthony D Keefe; Supriya Pai; Andrew Ellington
Journal:  Nat Rev Drug Discov       Date:  2010-07       Impact factor: 84.694

10.  Cell-type-specific, Aptamer-functionalized Agents for Targeted Disease Therapy.

Authors:  Jiehua Zhou; John J Rossi
Journal:  Mol Ther Nucleic Acids       Date:  2014-06-17       Impact factor: 10.183
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.